Inflammation Induces TDP-43 Mislocalization and Aggregation
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
TAR DNA-binding protein 43 (TDP-43) is a major component in aggregates of ubiquitinated proteins in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Here we report that lipopolysaccharide (LPS)-induced inflammation can promote TDP-43 mislocalization and aggregation. In culture, microglia and astrocytes exhibited TDP-43 mislocalization after exposure to LPS. Likewise, treatment of the motoneuron-like NSC-34 cells with TNF-alpha (TNF-α) increased the cytoplasmic levels of TDP-43. In addition, the chronic intraperitoneal injection of LPS at a dose of 1mg/kg in TDP-43(A315T) transgenic mice exacerbated the pathological TDP-43 accumulation in the cytoplasm of spinal motor neurons and it enhanced the levels of TDP-43 aggregation. These results suggest that inflammation may contribute to development or exacerbation of TDP-43 proteinopathies in neurodegenerative disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, peripheral LPS promotes TDP-43 mislocalization and aggregation, contributing to TDP-43 proteinopathies in neurodegenerative disorders, such as FTLD and ALS.243”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [243]
In the citing paper
“endotoxin promotes TDP-43 aggregation and neuropathology.”
From The endotoxin hypothesis of neurodegeneration (2019) · cites this paper as [103]
In the citing paper
“Addition of LPS to microglia or astrocytes in culture resulted in TDP-43 mislocalization and aggregation, and addition of peripheral LPS to TDP-43(A315T) transgenic mice resulted in TDP-43 aggregation in vivo [103].”
From The endotoxin hypothesis of neurodegeneration (2019) · cites this paper as [103]
In the citing paper
“This suggests a dual-hit hypothesis for ALS and FTD: increased endotoxin levels plus aggregable TDP-43 results in neurodegeneration.”
From The endotoxin hypothesis of neurodegeneration (2019) · cites this paper as [103]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576 · cited 8×
“In summary, the in vitro and in vivo results presented here suggest that inflammation, induced by stimuli of NF-κB signaling such as TNF-α or LPS, may be a mediator of TDP-43 proteinopathy which constitutes a pathological hallmark of ALS and FTLD [4–9].”
BackgroundMethodResultInfluentialArai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.093 · Cited by 2,732
TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J. C., Williams, K. L., Buratti, E., et al. (2008) · Science · doi:10.1126/science.1154584 · Cited by 2,630
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis
Kabashi, E., Valdmanis, P. N., Dion, P., Spiegelman, D., McConkey, B. J., Velde, C. V., Bouchard, J.-P., Lacomblez, L., Pochigaeva, K., Salachas, F., et al. (2008) · Nature Genetics · doi:10.1038/ng.132 · Cited by 1,544
ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors
Boillée, S., Vande Velde, C., & Cleveland, D. W. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.018 · Cited by 1,429
Mackenzie, I. R. A., Bigio, E. H., Ince, P. G., Geser, F., Neumann, M., Cairns, N. J., Kwong, L. K., Forman, M. S., Ravits, J., Stewart, H., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21147 · Cited by 992 · cited 1×
“We carried out the immunoblots with a widely used polyclonal antibody against TDP-43 [4,5, 8, 6,7, 29, 23], which reacts with both mouse and human TDP-43 species and yields a band at 43 kDa corresponding to the unmodified TDP-43.”
MethodTDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia
Mackenzie, I. R., Rademakers, R., & Neumann, M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70195-2 · Cited by 975
Van Deerlin, V. M., Leverenz, J. B., Bekris, L. M., Bird, T. D., Yuan, W., Elman, L. B., Clay, D., Wood, E. M., Chen-Plotkin, A. S., Martinez-Lage, M., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70071-1 · Cited by 723
TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration
Wegorzewska, I., Bell, S., Cairns, N. J., Miller, T. M., & Baloh, R. H. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908767106 · Cited by 706
Innate immunity: the missing link in neuroprotection and neurodegeneration?
Nguyen, M. D., Julien, J.-P., & Rivest, S. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn752 · Cited by 701
Self-citationBuratti, E., & Baralle, F. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104236200 · Cited by 700
Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration
Lee, E. B., Lee, V. M.-Y., & Trojanowski, J. Q. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3121 · Cited by 659 · cited 2×
“trigger TDP-43 redistribution from the nucleus to cytoplasm with formation of protein aggregates including axotomy, cell stressors, over-expression and mutations of TDP-43 gene [21, 17].”
BackgroundNeuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease
Philips, T., & Robberecht, W. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70015-1 · Cited by 646
TDP‐43 A315T mutation in familial motor neuron disease
Gitcho, M. A., Baloh, R. H., Chakraverty, S., Mayo, K., Norton, J. B., Levitch, D., Hatanpaa, K. J., White, C. L., Bigio, E. H., Caselli, R., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21344 · Cited by 619
Wils, H., Kleinberger, G., Janssens, J., Pereson, S., Joris, G., Cuijt, I., Smits, V., Ceuterick-de Groote, C., Van Broeckhoven, C., & Kumar-Singh, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912417107 · Cited by 587
Xu, Y.-F., Gendron, T. F., Zhang, Y.-J., Lin, W.-L., D'Alton, S., Sheng, H., Casey, M. C., Tong, J., Knight, J., Yu, X., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1630-10.2010 · Cited by 555
Barmada, S. J., Skibinski, G., Korb, E., Rao, E. J., Wu, J. Y., & Finkbeiner, S. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4988-09.2010 · Cited by 554
TDP-43 Binds Heterogeneous Nuclear Ribonucleoprotein A/B through Its C-terminal Tail
Buratti, E., Brindisi, A., Giombi, M., Tisminetzky, S., Ayala, Y. M., & Baralle, F. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505557200 · Cited by 460
The genetics and neuropathology of amyotrophic lateral sclerosis
Al-Chalabi, A., Jones, A., Troakes, C., King, A., Al-Sarraj, S., & van den Berg, L. H. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1022-4 · Cited by 398
TDP ‐ 43 mutation in familial amyotrophic lateral sclerosis
Yokoseki, A., Shiga, A., Tan, C., Tagawa, A., Kaneko, H., Koyama, A., Eguchi, H., Tsujino, A., Ikeuchi, T., Kakita, A., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21392 · Cited by 373
Swarup, V., Phaneuf, D., Dupré, N., Petri, S., Strong, M., Kriz, J., & Julien, J.-P. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20111313 · Cited by 338
Self-citationWalker, A. K., Spiller, K. J., Ge, G., Zheng, A., Xu, Y., Zhou, M., Tripathy, K., Kwong, L. K., Trojanowski, J. Q., & Lee, V. M.-Y. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1460-x · Cited by 336
LEIGH, P. N., WHITWELL, H., GAROFALO, O., BULLER, J., SWASH, M., MARTIN, J. E., GALLO, J. M., WELLER, R. O., & ANDERTON, B. H. (1991) · Brain · doi:10.1093/brain/114.2.775 · Cited by 331
Zhang, R., Miller, R. G., Gascon, R., Champion, S., Katz, J., Lancero, M., Narvaez, A., Honrada, R., Ruvalcaba, D., & McGrath, M. S. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.09.017 · Cited by 319
TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration
Benajiba, L., Le Ber, I., Camuzat, A., Lacoste, M., Thomas‐Anterion, C., Couratier, P., Legallic, S., Salachas, F., Hannequin, D., Decousus, M., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21612 · Cited by 303
Davidson, Y., Kelley, T., Mackenzie, I. R. A., Pickering-Brown, S., Du Plessis, D., Neary, D., Snowden, J. S., & Mann, D. M. A. (2007) · Acta Neuropathologica · doi:10.1007/s00401-006-0189-y · Cited by 299
Swarup, V., Phaneuf, D., Bareil, C., Robertson, J., Rouleau, G. A., Kriz, J., & Julien, J.-P. (2011) · Brain · doi:10.1093/brain/awr159 · Cited by 263
Self-citationProtocols for Neural Cell Culture
(1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90164-h · Cited by 248
Neumann, M., Kwong, L. K., Truax, A. C., Vanmassenhove, B., Kretzschmar, H. A., Van Deerlin, V. M., Clark, C. M., Grossman, M., Miller, B. L., Trojanowski, J. Q., et al. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000248554.45456.58 · Cited by 237
Progressive motor weakness in transgenic mice expressing human TDP-43
Stallings, N. R., Puttaparthi, K., Luther, C. M., Burns, D. K., & Elliott, J. L. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.06.017 · Cited by 209
Geser, F., Lee, V. M.-Y., & Trojanowski, J. Q. (2010) · Neuropathology · doi:10.1111/j.1440-1789.2009.01091.x · Cited by 195
Contribution of TARDBP mutations to sporadic amyotrophic lateral sclerosis
Daoud, H., Valdmanis, P. N., Kabashi, E., Dion, P., Dupré, N., Camu, W., Meininger, V, & Rouleau, G. A. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.062463 · Cited by 194
Ince, P. G., Highley, J. R., Kirby, J., Wharton, S. B., Takahashi, H., Strong, M. J., & Shaw, P. J. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0913-0 · Cited by 170
Protocols for Neural Cell Culture
FEDOROFF, S., & Richardson, A. K. (2001) · Humana Press eBooks · doi:10.1385/1592592074 · Cited by 128
Hart, M. P., & Gitler, A. D. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0996-12.2012 · Cited by 102
Recent Advances in the Genetics of the ALS-FTLD Complex
Morris, H. R., Waite, A. J., Williams, N. M., Neal, J., & Blake, D. J. (2012) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-012-0268-5 · Cited by 61
Zhang, R., Hadlock, K. G., Do, H., Yu, S., Honrada, R., Champion, S., Forshew, D., Madison, C., Katz, J., Miller, R. G., et al. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.08.012 · Cited by 57
Swarup, V., Audet, J.-N., Phaneuf, D., Kriz, J., & Julien, J.-P. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2267-12.2012 · Cited by 26
Self-citationElimination of Cell Types from Mixed Neural Cell Cultures
Devon, R. M. (1997) · Humana Press eBooks · doi:10.1007/978-1-4757-2586-5_15 · Cited by 8
Cited by
Lipopolysaccharide-induced neuroinflammation as a bridge to understand neurodegeneration
Batista, C. R. A., Gomes, G. F., Candelario-Jalil, E., Fiebich, B. L., & de Oliveira, A. C. P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092293 · Cited by 529
“TAR DNA-binding protein (TDP-43), a major component of cytoplasmic inclusions in sporadic and most familial ALS cases, appeared accumulated and aggregated in the cytoplasm of spinal motor neurons of TDP-43A315T transgenic mice after chronic LPS administration [145].”
BackgroundThe endotoxin hypothesis of neurodegeneration
Brown, G. C. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1564-7 · Cited by 457
Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies
Beers, D. R., & Appel, S. H. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30394-6 · Cited by 388
Inclusion body myositis: clinical features and pathogenesis
Greenberg, S. A. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0186-x · Cited by 273
The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases
Rey, N. L., Wesson, D. W., & Brundin, P. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.12.013 · Cited by 257
“, 2013), inflammation can in return promote the aggregation of some prion-like proteins in the brain and peripheral cells (Correia et al., 2015; He et al., 2013; Kitazawa et al., 2005; Lee et al., 2008; Sy et al., 2011; Vieira et al., 2015).”
Metadata
- Authors
- Correia, A. S., Patel, P., Dutta, K., & Julien, J.-P.
- Affiliations
- Centre hospitalier universitaire de Québec (CA)
- Institut Universitaire en Santé Mentale de Québec (CA)
- Corresponding author
- Julien, Jean-Pierre
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-10-07
- Volume
- 10
- Issue
- 10
- Pages
- e0140248
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4596857
- OpenAlex
- W1621668151
- Cited by
- 114
- References
- 39
- Citations by year
- 2026: 5 · 2025: 14 · 2024: 14 · 2023: 9 · 2022: 12 · 2021: 17 · 2020: 10 · 2019: 11 · 2018: 9 · 2017: 6 · 2016: 6
- FWCI
- 4.93
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- TDP-43, protein aggregation, mislocalization, neuroinflammation, lipopolysaccharide, microglia, astrocytes, TNF-α, amyotrophic lateral sclerosis, frontotemporal lobar degeneration, motor neurons, neurodegeneration
- MeSH terms
- Animals, Astrocytes, Cells, Cultured, DNA-Binding Proteins, Gene Expression Regulation, Humans, Inflammation, Lipopolysaccharides, Mice, Transgenic, RNA, Messenger, Point Mutation, Microglia, Mice, Protein Aggregates
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.